Longevity Investors Lunch returns to Davos
Top-class speakers, investment insights and pioneering dialogues on the topic of longevity
As part of the World Economic Forum (WEF) 2024 in Davos (CH), the eagerly awaited Longevity Investors Lunch will take place for the third time in a row. At a time when global awareness is focused on health and wellbeing, this event is an important platform that brings together investors, researchers, and thought leaders to explore the latest developments in longevity science.
The satellite event, which will take place on January 16 at the renowned Precise Tale Seehof Davos, will be a hotspot for innovation and discourse and will bring together luminaries from various fields. The joint event of Maximon and the Longevity Investors Conference Is the prelude to the big Longevity Investors Conference, The one from September 24 to 27, 2024 in Gstaad (CH) is held.
The event in Davos will be attended by 60 high-level investors and key opinion leaders, who will offer exciting panel discussions on various topics — from brain health to AI to nutritional supplements for a long life. Among others, these renowned experts and visionaries will be on stage:
Prof. Dr. Evelyne Yehudit Bischof, MD, MPH, Longevity Physician at Human Longevity Inc, Specialty: Internal Medicine
Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine, pioneer in AI applications in medicine
Rajiv Ahuja, Deputy Director of the Milken Institute Future of Aging, Expertise: Future Trends in Aging and Longevity
Hans Keirstead, Ph.D., President and CEO of AIVITA Biomedical, Inc, leading innovative biomedical research
Sophie Chabloz, co-founder and CPO of AVEA, expertise: entrepreneurship in the area of longevity
Dr. Emil Kendziorra, Founder and CEO of Tomorrow Bio; Chairman of the European Biostasis Foundation, Expertise: Biostasis and its Effects on Longevity
With a keynote from Andrew Steele, scientist and bestselling author of”Ageless: The new science of aging without aging,” the event promises intellectual depth and insights.
The hosts of the Longevity Investors Lunch, Dr. Tobias Reichmuth and Marc P. Bernegger (both co-founders of Maximon & Longevity Investors Conference), will open the event and highlight the importance of the emerging topic of longevity.
“We are looking forward to the Longevity Investors Conference, where we will have the opportunity to continue the important discussions we started in Davos and bring other leading figures from the longevity sector onto the stage to talk about key developments in the longevity industry and investment opportunities in this area,” says Marc P. Bernegger.
Dr. Reichmuth underlines the main motivation for organizing such an exclusive event, namely to address the lack of investor-oriented education and information within the emerging longevity industry.
As longevity becomes a huge driver of the global economy, this event promises trillions of dollars in opportunities to change society for the better. Breakthroughs in understanding the genetic pathways and biochemical processes that influence aging position longevity as an unprecedented investment opportunity for decades to come.
https://www.longevityinvestors.ch
E-mail: info@longevityinvestors.ch
References
Publiziert
6.9.2024
Kategorie
Lifestyle
Experte
As part of the World Economic Forum (WEF) 2024 in Davos (CH), the eagerly awaited Longevity Investors Lunch will take place for the third time in a row. At a time when global awareness is focused on health and wellbeing, this event is an important platform that brings together investors, researchers, and thought leaders to explore the latest developments in longevity science.
The satellite event, which will take place on January 16 at the renowned Precise Tale Seehof Davos, will be a hotspot for innovation and discourse and will bring together luminaries from various fields. The joint event of Maximon and the Longevity Investors Conference Is the prelude to the big Longevity Investors Conference, The one from September 24 to 27, 2024 in Gstaad (CH) is held.
The event in Davos will be attended by 60 high-level investors and key opinion leaders, who will offer exciting panel discussions on various topics — from brain health to AI to nutritional supplements for a long life. Among others, these renowned experts and visionaries will be on stage:
Prof. Dr. Evelyne Yehudit Bischof, MD, MPH, Longevity Physician at Human Longevity Inc, Specialty: Internal Medicine
Alex Zhavoronkov, Ph.D., founder and CEO of Insilico Medicine, pioneer in AI applications in medicine
Rajiv Ahuja, Deputy Director of the Milken Institute Future of Aging, Expertise: Future Trends in Aging and Longevity
Hans Keirstead, Ph.D., President and CEO of AIVITA Biomedical, Inc, leading innovative biomedical research
Sophie Chabloz, co-founder and CPO of AVEA, expertise: entrepreneurship in the area of longevity
Dr. Emil Kendziorra, Founder and CEO of Tomorrow Bio; Chairman of the European Biostasis Foundation, Expertise: Biostasis and its Effects on Longevity
With a keynote from Andrew Steele, scientist and bestselling author of”Ageless: The new science of aging without aging,” the event promises intellectual depth and insights.
The hosts of the Longevity Investors Lunch, Dr. Tobias Reichmuth and Marc P. Bernegger (both co-founders of Maximon & Longevity Investors Conference), will open the event and highlight the importance of the emerging topic of longevity.
“We are looking forward to the Longevity Investors Conference, where we will have the opportunity to continue the important discussions we started in Davos and bring other leading figures from the longevity sector onto the stage to talk about key developments in the longevity industry and investment opportunities in this area,” says Marc P. Bernegger.
Dr. Reichmuth underlines the main motivation for organizing such an exclusive event, namely to address the lack of investor-oriented education and information within the emerging longevity industry.
As longevity becomes a huge driver of the global economy, this event promises trillions of dollars in opportunities to change society for the better. Breakthroughs in understanding the genetic pathways and biochemical processes that influence aging position longevity as an unprecedented investment opportunity for decades to come.
https://www.longevityinvestors.ch
E-mail: info@longevityinvestors.ch